ArticleVaccines2021

12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.

Bingfeng Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.